Advanced Biomedical Technologies Inc
Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for… Read more
Market Cap & Net Worth: Advanced Biomedical Technologies Inc (ABMT)
Advanced Biomedical Technologies Inc (PINK:ABMT) has a market capitalization of $21.27K ($21.27K) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #44398 globally and #14081 in its home market, demonstrating a -50.00% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Advanced Biomedical Technologies Inc's stock price $0.00 by its total outstanding shares 70904850 (70.90 Million).
Advanced Biomedical Technologies Inc Market Cap History: 2016 to 2025
Advanced Biomedical Technologies Inc's market capitalization history from 2016 to 2025. Data shows change from $10.64 Million to $21.27K (-50.91% CAGR).
Advanced Biomedical Technologies Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Advanced Biomedical Technologies Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
10.47x
Advanced Biomedical Technologies Inc's market cap is 10.47 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $7.09 Million | $11.66K | -$948.82K | 608.26x | N/A |
| 2020 | $8.51 Million | $123.59K | -$672.00K | 68.85x | N/A |
| 2021 | $4.96 Million | $171.19K | -$729.44K | 28.99x | N/A |
| 2022 | $2.84 Million | $270.99K | -$515.49K | 10.47x | N/A |
Competitor Companies of ABMT by Market Capitalization
Companies near Advanced Biomedical Technologies Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Advanced Biomedical Technologies Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Advanced Biomedical Technologies Inc Historical Marketcap From 2016 to 2025
Between 2016 and today, Advanced Biomedical Technologies Inc's market cap moved from $10.64 Million to $ 21.27K, with a yearly change of -50.91%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $21.27K | -50.00% |
| 2024 | $42.54K | -98.50% |
| 2023 | $2.84 Million | 0.00% |
| 2022 | $2.84 Million | -42.86% |
| 2021 | $4.96 Million | -41.67% |
| 2020 | $8.51 Million | +20.00% |
| 2019 | $7.09 Million | -17.36% |
| 2018 | $8.58 Million | -19.33% |
| 2017 | $10.64 Million | 0.00% |
| 2016 | $10.64 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Advanced Biomedical Technologies Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $21.27K USD |
| MoneyControl | $21.27K USD |
| MarketWatch | $21.27K USD |
| marketcap.company | $21.27K USD |
| Reuters | $21.27K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.